Genenta Science (GNTA) Stock Chart & Stock Price History $3.18 +0.01 (+0.47%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genenta Science Stock Price Performance The Genenta Science (GNTA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 37.60%, with a year-to-date return of -26.99%. In the past month, the stock has decreased 9.00%, reflecting recent market activity. As of the latest close, Genenta Science traded at $3.16 with a market cap of $57.80 million and volume of 2,054 shares. Receive GNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.82%1 Month Performance-9.00%3 Month Performance-17.51%Year-To-Date Performance-26.99%1 Year Performance-37.60% GNTA Stock Chart for Wednesday, October, 8, 2025 GNTA Chart by TradingView Genenta Science Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$3.16$3.18+0.51%$3.39$3.0013,149 shs$58.09 million10/07/2025$3.22$3.16-1.86%$3.29$3.032,054 shs$57.80 million10/06/2025$3.24$3.22-0.46%$3.28$3.055,403 shs$58.89 million10/03/2025$3.31$3.24-2.12%$3.30$3.176,864 shs$59.17 million10/02/2025$3.27$3.31+1.07%$3.36$3.262,452 shs$60.45 million10/01/2025$3.21$3.27+2.03%$3.40$3.207,043 shs$59.81 million09/30/2025$3.18$3.21+0.79%$3.29$3.182,959 shs$58.62 million09/29/2025$3.11$3.18+2.38%$3.30$3.155,028 shs$58.16 million09/26/2025$3.12$3.11-0.45%$3.20$3.056,255 shs$56.81 million09/25/2025$3.15$3.12-0.95%$3.15$2.997,756 shs$57.07 million Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$2.94$3.15+7.14%$3.15$2.906,279 shs$57.61 million09/23/2025$2.97$2.94-0.88%$3.08$2.895,007 shs$53.77 million09/22/2025$2.92$2.97+1.71%$2.97$2.902,098 shs$54.25 million09/19/2025$3.04$2.92-4.08%$3.10$2.867,415 shs$53.33 million09/18/2025$3.14$3.04-3.22%$3.22$3.008,368 shs$55.60 million09/17/2025$3.05$3.14+3.02%$3.10$3.006,334 shs$57.45 million09/16/2025$3.06$3.05-0.23%$3.09$3.009,199 shs$55.77 million09/15/2025$2.99$3.06+2.34%$3.17$3.004,130 shs$55.89 million09/12/2025$2.75$2.99+8.58%$3.02$2.8223,513 shs$54.61 million09/11/2025$3.50$2.75-21.43%$3.50$2.56164,049 shs$50.30 million09/10/2025$3.44$3.50+1.74%$3.69$3.433,202 shs$64.02 million09/09/2025$3.49$3.44-1.43%$3.59$3.412,140 shs$62.92 million09/08/2025$3.53$3.49-0.99%$3.57$3.442,437 shs$63.83 million Related Companies Heron Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart ProQR Therapeutics Stock Chart Sagimet Biosciences Stock Chart Ventyx Biosciences Stock Chart Entrada Therapeutics Stock Chart Caribou Biosciences Stock Chart Black Diamond Therapeutics Stock Chart Cabaletta Bio Stock Chart Tonix Pharmaceuticals Stock Chart Receive GNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNTA) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
